Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

The influence of pre-transplant immune dysregulation on transplant outcomes for combined immunodeficiencies and immune dysregulatory disorders

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Thomas Fox & Emma Morris

L'influence de la dysrégulation immunitaire pré-transplantation sur les résultats de la greffe pour les immunodéficiences combinées et les troubles dysrégulateurs du système immunitaire

Études rétrospectives

Troubles héréditaires

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Thomas Fox & Emma Morris

Résultats des patients pédiatriques atteints de leucémies aiguës ayant reçu soit du cyclophosphamide post-transplantation, soit une greffe haplo-identique avec déplétion des lymphocytes TCR αβ/CD19+

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Allogénique - Haplo-identique

Principal investigator

Franco Locatelli

Survey on fertility procedures and outcomes for patients treated with CAR-T cell therapy

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT IN CARTILAGE HAIR HYPOPLASIA (CHH) A JOINT EBMT-CIBMTR STUDY

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Allogeneic haematopoietic stem cell transplantation in infantile osteopetrosis

Retrospective Studies

Inherited disorders

Type of treatment

Principal investigator

Outcome of haematopoietic stem cell transplant (HSCT) in patients with Chediak Higashi syndrome

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

A survey on secondary neoplasm post CART

Retrospective Studies

GoCART Coalition

Type of treatment

Principal investigator

Impact of prior B-cell directed immunotherapy (BCDI) on the outcome of CD19 CAR-T cell therapy in aggressive B-cell malignancies, on behalf of the GoCART Coalition initiative.

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Type of treatment

Principal investigator

The role of bridging therapy before CAR-T cell therapy in diffuse large B-cell lymphoma (DLBCL): An analysis of the LWP of the EBMT and the GoCART coalition.

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Type of treatment

Principal investigator

Philipp Berning

CAR-T in elderly patients

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Maribavir use for CMV infection in allogeneic stem cell transplantation: the real-world experience. A retrospective study of IDWP EBMT

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Annalisa Paviglianiti